Comparative analysis of the Mexico City Prospective Study and the UK Biobank identifies ancestry-specific effects on clonal hematopoiesis
Sean Wen(Wellcome/MRC Cambridge Stem Cell Institute), Jonathan Mitchell(AstraZeneca (Australia)), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Fengyuan Hu(Babraham Institute), Jonathan Emberson(University of Oxford), Jason Torres(University of Chicago), Abhishek Nag(King's College London), Katherine R. Smith(Murdoch Children's Research Institute), Oliver S. Burren(AstraZeneca (United Kingdom)), Douglas P. Loesch(University of Maryland, Baltimore), Andrew R. Harper(AstraZeneca (United Kingdom)), Ryan S. Dhindsa(Baylor College of Medicine), Keren Carss(AstraZeneca (United Kingdom)), Margarete A. Fabre(University of Cambridge), Jaime Berúmen(Yale University), Quanli Wang, Sebastian Wasilewski(AstraZeneca (United Kingdom)), Rory Collins(University of Oxford), Haeyam Taiy(AstraZeneca (United Kingdom)), Roberto Tapia‐Conyer(Universidad Nacional Autónoma de México), Slavé Petrovski(AstraZeneca (United Kingdom)), Sri V. V. Deevi(University of Cambridge), Ioanna Tachmazidou(AstraZeneca (United Kingdom)), Jesús Alegre-Díaz(Universidad Nacional Autónoma de México), Pablo Kuri‐Morales(Universidad Nacional Autónoma de México)
Cited by 13